Anti-Cancer Immunotherapies Targeting Telomerase
Anti-Cancer Immunotherapies Targeting Telomerase
About this item
Full title
Author / Creator
Publisher
MDPI
Journal title
Language
English
Formats
Publication information
Publisher
MDPI
Subjects
More information
Scope and Contents
Contents
Telomerase is a reverse transcriptase that maintains telomeres length, compensating for the attrition of chromosomal ends that occurs during each replication cycle. Telomerase is expressed in germ cells and stem cells, whereas it is virtually undetectable in adult somatic cells. On the other hand, telomerase is broadly expressed in the majority of...
Alternative Titles
Full title
Anti-Cancer Immunotherapies Targeting Telomerase
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465444
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7465444
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers12082260